MeCRU Research Unit (MeCRU), at SMU has been officially launched as the research site for Phase III Paediatric COVID-19 Vaccine study conducted by the Numolux Group and Sinovac on 10 September 2021. The very first child and the second one had the honor to receive their jabs which kick started the study.
Campus safety forum launched at SMU
Sefako Makgatho Health Sciences University (SMU) has taken a decisive step in tackling campus insecurity and gender-based violence (GBV) with the launch of the Campus Community Safety Forum (CCSF). The two-day Safety Engagement, held on 1–2 October 2025 in partnership...
